
    
      Randomized Phase II design, multicenter study, to assess the efficacy and safety of combined
      chemotherapy with Paclitaxel and Carboplatin versus a platinum free chemotherapy with
      Paclitaxel and Vinorelbine, within the combination therapies there are two different dosing
      intervals, which will be assessed as well (4 Arm study).
    
  